Ipilimumab Plus Nivolumab Versus Nivolumab Alone in Patients with Melanoma Brain Metastases (ABC): 7-Year Follow-Up of a Multicentre, Open-Label, Randomised, Phase 2 Study.
The Lancet Oncology（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined